The following study, funded by this federally funded, treatment-focused Gulf War Illness Congressionally Directed Medical Research Program (CDMRP), is currently enrolling Gulf War (deployed) and Gulf War Era (non-deployed) veterans.
More information will be posted to the research team's website. Information from the research team about the study is below, including how to contact them.
We would like to take this opportunity to thank you again for your interest or past participation in one of Dr. Beatrice Golomb’s studies. We continue to be grateful for your contribution and interest in her research.
We are conducting a study to examine the treatments that have been tried in order to alleviate symptoms from Gulf War Illness. This study will start to identify effective treatments, and their potential to help other Gulf War veterans.
We are enrolling a total of 400 study participants who live within the United States to participate in this study who meet [one of] the following criteria:
1. Gulf War Veterans: Veterans who were deployed to the Persian Gulf Region July 1990- August 1991 and have experienced health changes.
2. Veterans: Active member of the United States Military during the period 1989 – 1992, not deployed to the Persian Gulf and have experienced health changes.
Study participants will complete an online or paper survey. The survey will take approximately 1 – 3 hours. The survey will consist of questions that ask about your overall heath, well-being, symptoms, exposures, and treatments you have tried. After study completion, you will receive a $5 gift card to either Amazon.com or Starbucks (depending on your preference).
If there is a chance you might be interested in participating, please contact us at (858) 558-4950 x210 or x203 or email us at firstname.lastname@example.org or email@example.com to learn more. If you know of anyone else who might consider participating in our research study (either an affected Gulf War veteran, or Gulf Era [not deployed] veteran), perhaps you might be willing to pass on our contact information. We truly appreciate your participation and referrals.
Thank you for your time—and thank you, in advance, for your help, should you choose to provide it. We look forward to hearing from you.
Beatrice A. Golomb, MD, PhD
UCSD Efficacy of Treatments Tried Study